PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 153 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $204,851 | +19.8% | 5,912 | 0.0% | 0.01% | +16.7% |
Q1 2024 | $171,034 | +26.2% | 5,912 | 0.0% | 0.01% | +20.0% |
Q4 2023 | $135,562 | +50.9% | 5,912 | +9.8% | 0.01% | +25.0% |
Q3 2023 | $89,838 | -27.3% | 5,386 | +20.3% | 0.00% | -20.0% |
Q2 2023 | $123,655 | +53.6% | 4,477 | +27.9% | 0.01% | +66.7% |
Q1 2023 | $80,523 | +100.5% | 3,501 | 0.0% | 0.00% | +50.0% |
Q4 2022 | $40,156 | +38.5% | 3,501 | 0.0% | 0.00% | +100.0% |
Q3 2022 | $29,000 | +7.4% | 3,501 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $27,000 | -67.5% | 3,501 | 0.0% | 0.00% | -66.7% |
Q1 2022 | $83,000 | -30.8% | 3,501 | 0.0% | 0.00% | -25.0% |
Q4 2021 | $120,000 | +110.5% | 3,501 | +8.0% | 0.00% | +100.0% |
Q3 2021 | $57,000 | -60.7% | 3,241 | 0.0% | 0.00% | -60.0% |
Q2 2021 | $145,000 | +93.3% | 3,241 | +11.7% | 0.01% | +66.7% |
Q1 2021 | $75,000 | +44.2% | 2,901 | +12.4% | 0.00% | +50.0% |
Q4 2020 | $52,000 | +4.0% | 2,581 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $50,000 | +42.9% | 2,581 | +29.4% | 0.00% | 0.0% |
Q2 2020 | $35,000 | +288.9% | 1,995 | +49.2% | 0.00% | +100.0% |
Q1 2020 | $9,000 | 0.0% | 1,337 | 0.0% | 0.00% | – |
Q4 2019 | $9,000 | -43.8% | 1,337 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $16,000 | 0.0% | 1,337 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $16,000 | +100.0% | 1,337 | +37.8% | 0.00% | – |
Q1 2018 | $8,000 | -27.3% | 970 | +88.7% | 0.00% | -100.0% |
Q4 2017 | $11,000 | +37.5% | 514 | 0.0% | 0.00% | – |
Q3 2017 | $8,000 | +33.3% | 514 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | -14.3% | 514 | 0.0% | 0.00% | – |
Q1 2017 | $7,000 | – | 514 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 2,449,183 | $43,253,000 | 8.50% |
BVF INC/IL | 2,367,288 | $41,806,000 | 2.58% |
RTW INVESTMENTS, LP | 3,383,208 | $59,747,000 | 1.68% |
Novo Holdings A/S | 824,169 | $14,555,000 | 0.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,013,495 | $17,898,000 | 0.52% |
Sofinnova Investments, Inc. | 326,064 | $5,758,000 | 0.36% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $44,150,000 | 0.35% |
Virtus ETF Advisers LLC | 21,639 | $382,000 | 0.18% |
Baker Brothers Advisors | 1,911,446 | $33,756,000 | 0.15% |
King Wealth Management Group | 22,000 | $389,000 | 0.11% |